Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Interest Expenses (2022 - 2025)

TriSalus Life Sciences' Interest Expenses history spans 4 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 35.96% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $5.5 million, up 79.42%, while the annual FY2025 figure was $5.5 million, 79.42% up from the prior year.
  • Interest Expenses reached $1.5 million in Q4 2025 per TLSIW's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.5 million in Q3 2025 to a low of $1000.0 in Q4 2022.
  • Average Interest Expenses over 4 years is $665461.5, with a median of $877000.0 recorded in 2024.
  • Peak YoY movement for Interest Expenses: plummeted 40.0% in 2024, then soared 40200.0% in 2025.
  • A 4-year view of Interest Expenses shows it stood at $1000.0 in 2022, then skyrocketed by 200.0% to $3000.0 in 2023, then skyrocketed by 35500.0% to $1.1 million in 2024, then surged by 35.96% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Interest Expenses are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025).